Speaking to The Guardian, Dr Katie Doores, lead author of the study, explained the findings may have implications for a potential future vaccine.
She said: “People are producing a reasonable antibody response to the virus, but it’s waning over a short period of time and depending on how high your peak is, that determines how long the antibodies are staying around.
“Infection tends to give you the best-case scenario for an antibody response, so if your infection is giving you antibody levels that wane in two to three months, the vaccine will potentially do the same thing.
“People may need boosting and one shot might not be sufficient.”
Source: | Daily Express